Animal health market seen nearly doubling by 2035

Market Research Future projects the global animal health market will grow from $51.5 billion in 2025 to $117.2 billion by 2035, driven by pet care spending, livestock demand and new diagnostics. North America leads today, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - The animal health market is expanding as pet owners spend more on care and livestock operators look for ways to improve productivity and biosecurity. - The shift affects veterinary clinics, farms, diagnostics companies and drugmakers across companion animal and food production markets. - Stronger disease surveillance and food safety rules are widening demand for vaccines, pharmaceuticals and monitoring tools.

What happened: - Market Research Future said the global animal health market was valued at $47.3 billion in 2024. - The market is projected to rise from $51.5 billion in 2025 to $117.2 billion by 2035. - The forecast implies an 8.8% compound annual growth rate from 2025 to 2035. - The report was released from Pune, India, in August 2026. - Request a free sample of the report.

The details: - Pet humanization is increasing spending on preventive care, advanced therapeutics, oncology treatments and premium nutrition. - Livestock demand is rising with global appetite for meat, milk and eggs. - Veterinary health spending is rising on vaccines, specialized pharmaceuticals, health monitoring devices and nutritional supplements. - Technological advances are improving early detection and treatment through microfluidic diagnostics, point-of-care testing and AI-driven wearable devices. - Sensors that track vital signs, rumination and mobility are helping identify disease earlier in livestock. - Companion animals remain the largest animal type segment, driven by pet adoption and advanced treatments for dogs, cats and horses. - Livestock animals are the fastest-growing animal type segment, including cattle, poultry, swine and aquaculture. - Pharmaceuticals remain the leading product category, including parasiticides, antibiotics, anti-inflammatory drugs and biologicals. - Vaccines are one of the fastest-growing product categories. - Medicinal feed additives support gut health, disease resistance and nutrition efficiency. - Diagnostics are gaining adoption through molecular assays, rapid test kits, imaging equipment and point-of-care instruments. - Oral delivery remains the dominant administration route. - Parenteral administration remains critical for vaccines and rapid-action biologics. - Topical products remain widely used for parasiticides, skin care and wound treatment. - Veterinary hospitals and clinics remain the main end-use channel. - Point-of-care and in-house testing is expanding quickly. - Research institutes and academic centers continue to drive drug discovery and epidemiology research. - North America held about 42.5% of the market in 2024. - The United States accounts for most of North American revenue. - Europe remains a strong market with strict animal welfare rules and limits on antibiotic use. - Asia-Pacific is projected to post the highest CAGR through 2035. - South America is growing on cattle, poultry and aquaculture demand. - The Middle East and Africa is an emerging market supported by government food-production programs.

Between the lines: - The report points to a market moving from treatment toward prevention, monitoring and precision care. - Livestock health is becoming a food security issue as much as a veterinary one. - Digital tools and biologics are reshaping competition for animal health vendors. - Consolidation and R&D investment suggest larger players are racing to own the next generation of diagnostics and therapies. - Recent company focus areas include monoclonal antibodies, parasiticides, preventive biologics, vaccines, biosecurity and intelligent identification technologies.

What's next: - The market’s growth path depends on continued adoption of AI diagnostics, wearable trackers and rapid testing in clinics and on farms. - Gene therapies, customized vaccines and monoclonal antibodies are expected to play a bigger role by 2035. - Sustainable livestock practices and One Health programs are likely to keep shaping regulation and investment. - Market Research Future is positioning additional animal-health and adjacent sector reports for readers seeking more detail.

The bottom line: - Animal health is moving from a niche veterinary category to a broad, technology-driven market tied to pet care, livestock output and global food security.